increased sensitivity to induced morbidity/mortality_Cd19<tm1Tft>/Cd19<tm1Tft>

http://metadb.riken.jp/0009763I129SvC57BL6Cd19tm1TftCd19tm1TftCd19tm1Tft

increased sensitivity to induced morbidity/mortality_Cd19<tm1Tft>/Cd19<tm1Tft>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• CD19 antigen
  http://metadb.riken.jp/db/mgi_rdf/MGI:88319

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cd19<tm1Tft>/Cd19<tm1Tft>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cd19<tm1Tft>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129/Sv * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased sensitivity to induced morbidity/mortality
  http://purl.obolibrary.org/obo/MP_0009763

文献

http://purl.org/net/cito/citesAsAuthority

• J L. Gommerman, et.al., A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation., Journal of immunology (Baltimore, Md. : 1950), 2000, 165
  http://rdf.ncbi.nlm.nih.gov/pubmed/11120817